共 50 条
- [23] Re: Radiotherapy to the Prostate for Men with Metastatic Prostate Cancer in the UK and Switzerland: Long-Term Results from the STAMPEDE Randomised Controlled Trial JOURNAL OF UROLOGY, 2022, 208 (04): : 931 - 932
- [25] Towards accurate genomics for newly diagnosed metastatic prostate cancer Nature Cancer, 2024, 5 : 8 - 9
- [29] DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER JOURNAL OF UROLOGY, 2023, 209 : E490 - E490
- [30] Re: Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, et al. Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. Lancet 2018;392:2353-66 Metastatic Hormone-naive Prostate Cancer: A Multimodal Approach for a Heterogeneous Disease EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (03): : 390 - 390